CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all Representative Matters
Nov 5, 2020

Cybin Completes RTO of Clarmin Explorations, $45 Million Private Placement and Listing on NEO Exchange

Sherri M. Altshuler, Melanie Cole, Danny Kharazmi, Sean Green, Meredith McCann and Barbara Worndl

On November 5, 2020, Cybin Inc. (the “Company”), completed a reverse takeover of Clarmin Explorations Inc. (“Clarmin”) pursuant to the terms of an amalgamation agreement among Cybin Corp., Clarmin and a wholly-owned subsidiary (“SubCo”) of Clarmin (the “Reverse Takeover”).

The Reverse Takeover was completed by way of a “three-cornered” amalgamation whereby Cybin Corp. merged with SubCo to form a wholly owned subsidiary of Clarmin. Clarmin subsequently changed its name to “Cybin Inc.” Following completion of the Reverse Takeover, the common shares of the Company began trading on the NEO Exchange under the symbol “CYBN.”

In connection with the Reverse Takeover, Cybin Corp. completed a private placement offering of 60 million subscription receipts at a price of $0.75 per subscription receipt for aggregate gross proceeds of $45 million. On completion of the Reverse Takeover, the subscription receipts were exchanged for common shares of the Company.

The Company now focuses on the business of Cybin Corp., which includes psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions.

Aird & Berlis acted for Cybin Corp. and the Company with a team that included Sherri Altshuler, Melanie Cole, Danny Kharazmi, Sean Green and Meredith McCann (Capital Markets/M&A) and Barbara Worndl (Tax).

Related Representative Matters

Representative Matters
Shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheries Ltd. Complete $110 Million Sale Joel M. Rose, Jeremy D. Burke, Jesse Rosensweet, Joanne C. Coldwell, Barbara Worndl, Sarah Newman, Jessie Lewis and Emily Chittick Oct 26, 2021 Aird & Berlis advised the shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheri... Aird & Berlis advised the shareholders of Suncoast Seafood Inc. and Raymond O’Neill & Son Fisheries Ltd.
Representative Matters
Ronin Equity Partners Acquires Minus Forty Group, QBD Group Jack Bernstein, Martin Kovnats and Liam Tracey-Raymont Sep 28, 2021 Ronin Equity Partners, LLC ("Ronin"), a New York-based private equity firm, completed its simulta... Ronin Equity Partners, LLC ("Ronin"), a New York-based private equity firm, completed its simultaneous acquisition of the QBD Group and the Minus Forty Group, two North American manufacturers of commercial refrigeration equipment, including freezers, coolers and refrigerated merchandising product...
Representative Matters
Biomind Completes RTO of Crosswinds Holdings, $6 Million Private Placement and Listing on NEO Exchange Richard M. Kimel, Marek Lorenc and Danny Kharazmi Sep 23, 2021 Biomind Labs Inc. (formerly Crosswinds Holdings Inc.), completed a plan of merger under the BVI B... Biomind Labs Inc. (formerly Crosswinds Holdings Inc.), completed a plan of merger under the BVI Business Companies Act 2004 (British Virgin Islands) between Biomind Research Corp and a wholly owned subsidiary of the Company, which resulted in the reverse...